ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,100.11
0.19%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,663.90
0.43%
Brent Oil
73.265
0.58%
Bitcoin
96,908.33
2.70%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Skinbiotherapeutics Plc (SBTX)

  7. Skinbiotherapeutics Plc (SBTX) News

Skinbiotherapeutics (SBTX)

Skinbiotherapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:SBTX
DateTimeSourceHeadlineSymbolCompany
19/11/202407:00RNS Regulatory NewsSkinBioTherapeutics PLC Finalisation of commercial agreement with CrodaLSE:SBTXSkinbiotherapeutics Plc
25/10/202415:29RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
23/10/202415:34Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecastLSE:SBTXSkinbiotherapeutics Plc
23/10/202413:40RNS Regulatory NewsSkinBioTherapeutics PLC Integration update and share price movementLSE:SBTXSkinbiotherapeutics Plc
17/10/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
16/10/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Issue of Equity and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
11/10/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Acquisition and Financial UpdateLSE:SBTXSkinbiotherapeutics Plc
04/10/202413:02RNS Regulatory NewsSkinBioTherapeutics PLC Notice of Investor Meet Company PresentationLSE:SBTXSkinbiotherapeutics Plc
19/09/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Final testing of SkinBiotix by Croda completedLSE:SBTXSkinbiotherapeutics Plc
13/08/202411:49RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
08/08/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
02/08/202412:43Alliance NewsAlliance NewsSkinBioTherapeutics lands GBP1.6 million investment to support growthLSE:SBTXSkinbiotherapeutics Plc
02/08/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Investment of £1.56m from new investorsLSE:SBTXSkinbiotherapeutics Plc
29/07/202413:46Alliance NewsAlliance NewsSkinBio says trading "better than expected" as revenue growsLSE:SBTXSkinbiotherapeutics Plc
29/07/202406:01RNS Regulatory NewsSkinBioTherapeutics PLC Appointment of Senior Croda VP as Board AdvisorLSE:SBTXSkinbiotherapeutics Plc
29/07/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Full year trading updateLSE:SBTXSkinbiotherapeutics Plc
23/07/202414:00Alliance NewsAlliance NewsREPEAT: SkinBio announces closure of its convertible bond facilityLSE:SBTXSkinbiotherapeutics Plc
23/07/202413:59Alliance NewsAlliance NewsSkinBio announces closure of its convertible bond facilityLSE:SBTXSkinbiotherapeutics Plc
23/07/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Closure of Convertible Bond FacilityLSE:SBTXSkinbiotherapeutics Plc
22/07/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
15/07/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Notice of Business Update & Investor PresentationLSE:SBTXSkinbiotherapeutics Plc
28/06/202414:16RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
18/06/202415:37Alliance NewsAlliance NewsEARNINGS AND TRADING: Cordel thrilled by Middle East contract winLSE:SBTXSkinbiotherapeutics Plc
18/06/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC AxisBiotix Acne study reports positive dataLSE:SBTXSkinbiotherapeutics Plc
29/05/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
11/04/202410:44RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
05/04/202406:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice & Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
22/03/202411:34Alliance NewsAlliance NewsSkinBioTherapeutics half-year revenue jumps on UK-based salesLSE:SBTXSkinbiotherapeutics Plc
22/03/202407:00RNS Regulatory NewsSkinBioTherapeutics PLC Half-year ReportLSE:SBTXSkinbiotherapeutics Plc
18/03/202414:17Alliance NewsAlliance NewsSkinBioTherapeutics announces research into wound healing bacteriumLSE:SBTXSkinbiotherapeutics Plc
 Showing the most relevant articles for your search:LSE:SBTX

Your Recent History

LSE
POLX
Polarean Imaging
LSE
LLOY
Lloyds Banking
LSE
STX
Shield Therapeutics
LSE
POS
Plexus
LSE
NESF
Nextenergy Solar
LSE
LIO
Liontrust Asset Management
LSE
BARC
Barclays
LSE
JET2
Jet2
LSE
NEXN
Nexxen
LSE
MIN
Minoan
LSE
W7L
Warpaint London
LSE
AAZ
Anglo Asian Mining
LSE
JD.
Jd Sports Fashion
LSE
CBG
Close Brothers
LSE
EME
Empyrean Energy
LSE
RUBI
Rubicon Software
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06